ALGS
Price
$7.21
Change
+$1.17 (+19.34%)
Updated
Jun 6, 04:09 PM (EDT)
Capitalization
36.99M
RLAY
Price
$3.35
Change
+$0.12 (+3.70%)
Updated
Jun 6, 04:38 PM (EDT)
Capitalization
553.77M
67 days until earnings call
Interact to see
Advertisement

ALGS vs RLAY

Header iconALGS vs RLAY Comparison
Open Charts ALGS vs RLAYBanner chart's image
Aligos Therapeutics
Price$7.21
Change+$1.17 (+19.34%)
Volume$2.5K
Capitalization36.99M
Relay Therapeutics
Price$3.35
Change+$0.12 (+3.70%)
Volume$1.75K
Capitalization553.77M
ALGS vs RLAY Comparison Chart
Loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGS vs. RLAY commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Buy and RLAY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ALGS: $6.05 vs. RLAY: $3.23)
Brand notoriety: ALGS and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 49% vs. RLAY: 45%
Market capitalization -- ALGS: $36.99M vs. RLAY: $553.77M
ALGS [@Biotechnology] is valued at $36.99M. RLAY’s [@Biotechnology] market capitalization is $553.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALGS and RLAY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 5 TA indicator(s) are bullish while RLAY’s TA Score has 6 bullish TA indicator(s).

  • ALGS’s TA Score: 5 bullish, 2 bearish.
  • RLAY’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both ALGS and RLAY are a good buy in the short-term.

Price Growth

ALGS (@Biotechnology) experienced а +5.49% price change this week, while RLAY (@Biotechnology) price change was +4.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.61%. For the same industry, the average monthly price growth was +17.33%, and the average quarterly price growth was +3.50%.

Reported Earning Dates

ALGS is expected to report earnings on Mar 10, 2025.

RLAY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+11.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($554M) has a higher market cap than ALGS($37M). RLAY YTD gains are higher at: -21.602 vs. ALGS (-84.814). ALGS has higher annual earnings (EBITDA): -83.89M vs. RLAY (-373.07M). RLAY has more cash in the bank: 710M vs. ALGS (138M). ALGS has less debt than RLAY: ALGS (7.87M) vs RLAY (47.2M). RLAY has higher revenues than ALGS: RLAY (7.68M) vs ALGS (3.27M).
ALGSRLAYALGS / RLAY
Capitalization37M554M7%
EBITDA-83.89M-373.07M22%
Gain YTD-84.814-21.602393%
P/E RatioN/AN/A-
Revenue3.27M7.68M43%
Total Cash138M710M19%
Total Debt7.87M47.2M17%
TECHNICAL ANALYSIS
Technical Analysis
ALGSRLAY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVS3.900.15
+4.13%
Corvus Pharmaceuticals
ASO42.900.10
+0.23%
Academy Sports and Outdoors
LGL6.610.01
+0.15%
LGL Group (The)
IDXX522.21-2.65
-0.50%
IDEXX Laboratories
ANGI16.60-0.38
-2.27%
Angi Inc

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with XNCR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
+1.68%
XNCR - ALGS
41%
Loosely correlated
+0.22%
STRO - ALGS
39%
Loosely correlated
-9.37%
RLAY - ALGS
36%
Loosely correlated
N/A
CRNX - ALGS
35%
Loosely correlated
+0.59%
ARWR - ALGS
33%
Loosely correlated
-1.73%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with BCYC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then BCYC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
N/A
BCYC - RLAY
51%
Loosely correlated
+0.59%
XNCR - RLAY
51%
Loosely correlated
+0.22%
IMNM - RLAY
47%
Loosely correlated
+1.16%
BDTX - RLAY
46%
Loosely correlated
-2.36%
RVMD - RLAY
45%
Loosely correlated
-0.42%
More